Kiniksa Pharmaceuticals International Insider Sold Shares Worth $2,347,335, According to a Recent SEC Filing

MT NewswiresMay 2 04:04 ET

3 Stocks Including Kiniksa Pharmaceuticals International That May Be Priced Below Intrinsic Value Estimates

Yahoo FinanceMay 1 07:38 ET

An Intrinsic Calculation For Kiniksa Pharmaceuticals International, Plc (NASDAQ:KNSA) Suggests It's 41% Undervalued

Yahoo FinanceApr 30 06:38 ET

Jefferies Maintains Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Raises Target Price to $45

Moomoo NewsApr 30 03:32 ET · Ratings

Kiniksa Pharmaceuticals Announces GRAMMY Award-Winning Country Star, Carly Pearce, Joins the Life DisRPted Campaign, Adding to Voices Advocating for Awareness of Recurrent Pericarditis

Kiniksa PharmaceuticalsApr 30 00:00 ET

Kiniksa Pharmaceuticals Price Target Raised to $45.00/Share From $40.00 by Jefferies

Dow JonesApr 29 18:03 ET · Ratings